This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tito's Inspiration Mars: The Fly in the Flyby Ointment

A reviewer of Poynter's memoir of the Biosphere 2 experience on the American Scientist Web site speaks for much of the scientific community when she says book and project both seemed "haphazard" and "seem to have lacked a clear plan."


Real Inspiration

At the press conference quoting Helen Keller, Dr. Clark said: "Life is either a daring adventure or nothing."

Maybe so, but how we approach it can mean the difference between a daring successful adventure and a daring disastrous adventure. (I had this very conversation with my 17-year-old daughter this morning -- every parent knows what I'm talking about.)

Tito needs funding -- he's not a billionaire, he can't afford the Mars trip alone and that's a good thing. That need might finally force him out of his wealth bubble, force him and the Biosphere folks out of the public eye and get good, disciplined people and companies involved as active partners.

If he can't make that leap, he needs to turn his foundation into something else, an information clearinghouse for Mars missions perhaps. He does not have the freedom to do a half-baked job of a manned Mars flyby, to muck it up. That's one thing he can't do.

This is no mere personal quest, no joyride, no clubhouse game. As he and his team were fond of noting at the press conference, they are setting themselves up to represent the entire species with this project. If they're going to be so bold as to claim they can do it, they have an obligation to get it right.

-- Written by Carlton Wilkinson in Asbury Park
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs